Language selection

Search

Patent 1232204 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1232204
(21) Application Number: 1232204
(54) English Title: REDUCING SEBUM SPREADING
(54) French Title: COMPOSE POUR EMPECHER LE SEBUM DE SE REPANDRE
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 31/7012 (2006.01)
  • A61K 31/16 (2006.01)
  • A61P 17/10 (2006.01)
(72) Inventors :
  • HERSTEIN, MORRIS S. (United States of America)
  • SMITH, WALTER P. (United States of America)
(73) Owners :
(71) Applicants :
(74) Agent: OSLER, HOSKIN & HARCOURT LLP
(74) Associate agent:
(45) Issued: 1988-02-02
(22) Filed Date: 1983-09-16
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
432,621 (United States of America) 1982-10-04

Abstracts

English Abstract


REDUCING SEBUM SPREADING
Abstract
A method and composition for treating human
skin, having applicability to oily skin and acne in
order to improve the condition thereof by reducing the
spreadability of sebum on the skin surface; the inven-
tion involving the application to human skin so char-
acterized of a composition comprising, as an active
component to reduce the spreadability of sebum, an
effective amount of a quaternary halide of an N,N,N-
trialkylaminoalkylene gluconamide.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclu-
sive property or privilege is claimed are defined as follows:
1. A topical anti-acne composition comprising an
anti-acne active ingredient and, as an active component to re-
duce sebum spreading, an effective amount of a quaternary hal-
ide of an N,N,N-trialkylaminoalkylene gluconamide having the
formula:
< IMG >
wherein X is chloro or bromo and n is an integer of from 2 to
4.
2. The composition of claim 1 wherein n is the in-
teger 3.
3. A topical anti-acne composition comprising an
anti-acne active ingredient and, as an active component to re-
duce sebum spreading, an effective amount of a quaternary chlo-
ride of an N,N,N-trialkylaminoalkylene gluconamide having the
formula:
< IMG >
4. The composition of claim 3 wherein the amount
of said quaternary chloride in said composition is at least
0.05 percent by weight.
5. The composition of claim 3 wherein the amount
-12-

of said quaternary chloride in said composition is from about
0.3 to about 6 percent by weight.
6. The composition of claim 3 wherein the amount
of said quaternary chloride in said composition is from about
0.5 to about 3 percent by weight.

Description

Note: Descriptions are shown in the official language in which they were submitted.


V-1210
`~2;~2~
SEDUCING SERUM SPUDDING
Background of the Invention
Serum, or skin oil, is produced in the sea-
Swiss glands located in the pilosebaceou~ apparatus of
the skin and reaches the skin surface through the duct
of the hair follicles. The presence of excessive
amounts of serum on the skin surface often results in
an unattractive cosmetic condition commonly known as
"oily skin". Serum also plays an important role in
lo the pathogenesis of acne. Setaceous gland activity is
significantly increased in acne subjects and indivi-
duals with the most severe acne often haze the highest
serum secretion rates.
The spreading of serum on the skin surface
is thus an important cosmetic parameter since its
distribution on the spin surface can determine the
appearance of oiliness or greasiness and can contra-
byte to the severity of acne.
It is advantageous, therefore, to have
available means for reducing the flow of serum over
the surface of human skin, with particular regard to
skin characterized by an excessive secretion or pros-
once of serum on the surface and to affected skin
areas of acne patients.
It has now been discovered that qua ternary
halide salts of N,N,N-trialkylaminoalkylene glucon-
aside may be employed to effectively so reduce the
spread ability of serum.

V-1210
~2~22~4
Related References
_
The qLIaternary halide salts of N,N,N-tri-
alkylaminoalkylene gluconamide used in this invention
are described in US. Patents 3,766,267 and 3,855,290
for use as emollients in topical and cosmetic
applications. Their use, however, as agents capable of
effectively reducing the spreadabilbility of serum on
human skin has not been recognized heretofore.
Summary of the Invention
The present invention relates to a method
and composition for the topical application of a
qua ternary halide salt of an N,N,N-trialkylamino-
alkaline gluconamide for the treatment of human skin
(including the scalp) by reducing the spread ability of
serum thereon. Such method provides for the physic-
logically effective treatment of human skin and has
beneficial applications such as, for example, in come-
tics formulated for particular use on oily skin, such
as, for example, pore cleansers, scalp and hair sham
pros and conditioners, and the like, following applique-
lion of which the skin is perceived and felt to be less
oily, and in the treatment of acne wherein the reduce
lion of excessive spreading of serum is particularly
desirable to help prevent spreading of the acne condo-
lion.
Detailed Des~riptiGn of the Invention
.
The active compounds employed in this invent
lion are qua ternary halide salts of N,N,N-trialkyl-
--2--

z V-1210
aminoalkylene gluconamide having the formula:
C13
~2-(cHoH)4-c-NH-~cH2)n-Nl-cH2-cH2 X- tip
SHEA
wherein X is sheller or broom and n is an integer of
from 2 to 4, and preferably 3, of which the qua ternary
chloride salt having the following formula is most
preferred:
H H H OH H O OH 3
HO--C--C--C--C--C--C-NH- ( SHEA ) 3-N---CH2-(~H20H Of - ( II )
H OH OH H OH SHEA
The preferred qua ternary chloride salt of
formula (II), chemically known asoC-gluconamidopropyl
dimethyl-2-hydroxyethyl ammonium chloride (CTFA name =
Quaternium 22) is commercially available as a free-
flowing 60~ aqueous solution (i.e., 60% active)
marketed by the Van Dye Company, Inc. under the trade-
mark "Sorrowful 60".
It has now been found that the qua ternary
halides of formula (I) and, most preferably, of formula
(II) markedly reduce the spread ability of serum on
human skin. The improvement provided by the present
invention involves the use of this beneficial effect in
treating spin conditions characterized either (i) by
excessive secretion or presence of serum on the skin
surface, e.g., oily skin, or (ii) by acne, and thereby
improve the condition thereof by the topical applique-
lion of appropriate compositions containing said
qua ternary halides. Such topical compositions may be
either cosmetic formulations for use on oily skin or
therapeutically active anti-acne formulations.
--3--

V-1210
The particular type of topical cosmetic come
position, which may include, for example, hand, face
and body lotions and creams, scalp and hair condition-
east lotions, gels and shampoos, just to name a few, is
not critical. Such types of compositions are readily
prepared by skilled cosmetic chemical formulators.
Similarly, the particular type of anti-acne composition
is not critical nor, for that matter, is the particular
therapeutic anti-acne active ingredient, for example,
Bunnell peroxide, sulfur, resorcinol, derivatives of
retinoic acid, chlorhydroxyquinoline, hormonal and
antibacterial agents, and the like. The aforementioned
~uaternary halides of formulas (I) and (II) are non-
toxic to human skin, are compatible with hydrophilic
adjutants and can be readily incorporated into such
topical compositions.
In preparing such compositions, it is quite
apparent that the product should not be formulated in
) such manner or include any vehicle or ingredient which
would substantially in effectuate the activity of said
halides (I) and (II) in reducing serum spread ability on
the skin surface when the product is topically applied.
It is also evident that the produce should be physic-
logically compatible with the skin and be cosmetically
elegant.
For purposes of this invention, an effective
amount of a qua ternary halide of formula (I) and, most
preferably, of formula (II) is included as an active
ingredient to reduce the spread ability of serum on skin
in the topical compositions for use herein and, goner-
ally, at least about ~05 percent by weight, based on

~23~ V-l 21 0
the weight of the total composition (i.e. "% w/w"), is
wound suitable although from about 0.3 to about 6% w/w
is preferred and, most preferably, from about 0.5 to
about 3% w/w.
The instant invention thus provides a method
of treating human skin, characterized by an excessive
) secretion of serum or by acne, to improve the condition
thereon by reducing the spread ability of serum on the
skin surface which comprises topically applying to
human skin so characterized a composition comprising,
as an active component to reduce the spread ability of
serum, an effective amount of a qua ternary halide of
N,N,N-trialkylaminoalkylene gluconamide of formula (I)
or formula IT The invention also provides novel
anti-acne compositions for topical application comprise
in, as an active ingredient to reduce serum spreading,
an effective amount of said halides (I) or (II).
The method of this invention, compositions
for use therein and the reduction in serum spreadable-
fly afforded by said qua ternary halides will be thus-
treated and better understood by reference to the
following examples. The procedure utilized in testing
for reduction in serum spread ability is as follows.
Testing Protocol:
From 2 to 4 mg/cm2 of the material to be
tested is placed on the back of the hand and spread
evenly covering a circular area of about 2 inches in
diameter. After application of the testing material, a
period of one hour is allowed at room temperature for
equilibration. After this hour, a 4 pi drop, measured

V-1210
;~232~
from a micro pipette of artificial serum supplemented
with 13% by weight of skyline is deposited sub Stan-
tidally in the center of the treated area. The formula-
lion for artificial serum is
Ingredients % w/w
Skyline l8.0
Corn Oil 7.0
1:1 Mix of Glycerol Dioleate:Oleic Acid 1.0
Oleic Acid 27.0
Sorrowful 140 (Decal Owlet) 43.5
Cholesterol Palpitate 1.0
Cholesterol 2.5
100.0
After a spreading period of 10 minutes, a
1 cm diameter glass cylinder is placed over the center
and the serum within the confines of the cylinder is
extracted. The extraction is performed by pupating
2 x 0.5 ml allocates of hexane into the glass cylinder
for 30 seconds without agitation. Both hexane extracts
are each pipette into a test tube and evaporated to
dryness by a nitrogen gas evaporator. The residue is
resolubilized with 0.2 ml hexane and 10 us of twitter-
cosine is added to the sample as an internal standard.
The amount of serum within the glass cylinder is
I precisely determined by gas-liquid chromatography (GLC)
via determination of the amount of skyline contained
in the extract. From this data, the area covered by
the spreading of the artificial serum is calculated.
The greater the amount of skyline recovered from the
extract, the greater toe reduction in serum spreading.

V-12~0
I 4`
Example 1
A cosmetic product, applicable to oily skin,
for deeply cleaning spin pores is prepared in
accordance with the following formulation. All amounts
are in parts by weight unless otherwise indicated.
Table I
.. .. . _
Ingredient Composition
Alcohol* 49.1 v/v
Salicylic acid 0.5
10 Acetone 0.9 v/v
Ceteareth-27 (surfactant) 1.0
Propylene glycol OWE
Menthol 0.05
Tartaric acid 0.25
15 Fragrance 0.05
Water, purified us ad 100.00 v/v
*Equivalent to 43.2% v/v Alcohol, Absolute.
Example 2
Compositions of Sorrowful 60 admixed with the
skin pore cleanser of Example 1 in the percent concern-
tractions indicated in Table II are prepared and the
percent reduction in serum spreading for each
composition is recorded.

I V-1210
Table II
. . . _ . _
Composition Example 1 Reduction In
Cleaner Admixed With: Serum Spreading*
a. 0.0~ w/w Sorrowful 60 (Control) negligible (base
line)
b. Oily " " " " 12.3
c. 0.5% " " " " 26.4
d. 1.0% " " " " 41.2
e. 1.5~ " " " " 29.4**
lo f. 2.0% " " " " 38.8
g. 2.5% " " " " 33.8**
h. 3.0~ " " " " 42.4
i. 5.0% " " " " 70.4
*Average reading of six tests.
**Percentage is atypically low due to inclusion of one
non-responsive subject.
Example 3
This example illustrates the marked reduction
in serum spread ability on human skin when Sorrowful 60
is added to two commercially available creams for
treating acne (each containing 10% bouncily peroxide as
the active anti-acne ingredient).
Table III
-Clearasil~
Acne Treatment % w/w % Reduction In
Cream* Sorrowful 60 Serum Spreading
A. Tinted 0 zero
2 46
B. Vanishing 0 9
" 2 21
*Marketed by Richardson-Vicks Inc., Wilson, Connecticut

V-1210
~232Z~?4
Example 4
The following basic shampoo formulations,
(A) one without and (B) one with l% w/w Sorrowful 60, are
prepared and tested for percent reduction in serum
spread ability.
Table IV _ _
Reduction In
Ingredients % w/w bum Spreading
A. Sodium laurel ether
sulfate (30%) 40.0 4%
Citric acid an hydrous 0.3
Water 59.7
B. Sodium laurel ether
sulfate (30%) 40.0 60%
lo Citric acid an hydrous 0.3
Sorrowful 60 1.0
Water 58.7
_
Example 5
The following formulation for an oil-free
moisturizer-cleanser containing 3% w/w Sorrowful 60 is
prepared. When tested, the percent reduction in serum
spreading is 46%. In contrast, the identical
formulation without the Sorrowful 60 (i.e., replaced by
water) measures a 35% reduction.

V-1210
Table V
~L--dients % w/w
Part A:
Purified Water 79.89
Carbomer ~34 lgellina agent) 0.20
Methyl paraberl ~.18
Part B:
Deionized water 2.00
lo Sodium laurel amino preappoint 2~00
Amphoteric-2 3.00
Part C:
Purified water 2.00
Sodium hydroxide pullets
Part D:
Purified water 1,00
Sorrowful 60 3.00
Part E:
Myristyl acetate l.00
Cetostearyl alcohol 1.00
Myristic acid l.50
Glycerol dilaurate 1.50
Myristyl alcohol 0.25
Propel paraben Oslo
Part F:
Imidazolidinyl urea 0.30
Purified water 1.00
Total 100.00
_ _ _ . . .. _ ... _ . _
Prepare Part A by dissolving the methyl pane-
Ben in the water and then adding the Carbomer 934 and
heating to 70C. Separately prepare Parts B and D and
heat each to 75-80C. Mix Parts B and D together and
combine with Part A. Prepare Part E and heat to 80C
and add to previous mixture with stirring. Prepare
Part C and add to previous mixture with stirring.
Allow mixture to cool. At about 45C the emulsion goes
through an inversion phase and changes color by turning
white. Prepare Part F and mix into previous mixture at
about 40 C. Let mixture cool to room temperature.
--10--

V-1210
32~
It will be understood by those having skill
in the art that the invention is not limited to the
specific examples which have been offered as particular
embodiments and that modifications can be made without
departing from the spirit thereof.

Representative Drawing

Sorry, the representative drawing for patent document number 1232204 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2013-11-12
Inactive: IPC assigned 2013-07-03
Inactive: IPC assigned 2013-07-03
Inactive: First IPC assigned 2013-07-03
Inactive: First IPC derived 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 2005-02-02
Grant by Issuance 1988-02-02

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
None
Past Owners on Record
MORRIS S. HERSTEIN
WALTER P. SMITH
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1993-08-06 1 14
Abstract 1993-08-06 1 13
Claims 1993-08-06 2 34
Drawings 1993-08-06 1 10
Descriptions 1993-08-06 11 291